BMO Capital Initiates Coverage on Astera Labs with Outperform Rating
BMO Capital has initiated coverage on Astera Labs, Inc. with an "Outperform" rating.
Stocks · News reference
Analysts initiated coverage: BMO rated Astera Labs Outperform with a $375 target; Citi rated ATI Buy with a $229 target.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
BMO Capital has initiated coverage on Astera Labs, Inc. with an "Outperform" rating.
HC Wainwright has initiated coverage on Kardigan, Inc. with a 'Buy' rating and a price target of $42.00 per share.
Filed: 2026-11-04 AccNo: 0001628280-26-070258 Size: 151 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Netskope, Inc. has scheduled the release of its financial results for the fiscal third quarter ended October 31, 2026, for December 2, 2026.
Cantor Fitzgerald has initiated research coverage on Netskope, assigning the stock an Overweight rating and a price target of $28.
Netskope announced it will release fiscal Q3 2026 financial results on December 2, 2026, followed by a management conference call. The company, a leader in cloud and AI security, serves over 30 Fortune 100 customers through its Netskope One platform and Zero Trust Engine.